Table 2 Clinicopathological associations of DNER expression in triple negative breast cancer.

From: DNER promotes epithelial–mesenchymal transition and prevents chemosensitivity through the Wnt/β-catenin pathway in breast cancer

Variables

Low

N = 47 (%)

High

N = 51 (%)

P value*

Age at diagnosis, years

  

0.818

≤50

12 (25.5)

12 (23.5)

 

>50

35 (74.5)

39 (76.5)

 

Grade

  

0.037

Well

6 (12.8)

2 (3.9)

 

Moderately

12 (25.5)

6 (11.8)

 

Poorly

29 (61.7)

43 (84.3)

 

Tumour size (cm)

  

0.048

≤2

23 (48.9)

15 (29.4)

 

>2

24 (51.1)

36 (70.6)

 

Lymph node metastasis

  

0.113

Negative

25 (53.2)

19 (37.3)

 

Positive

22 (46.8)

32 (62.7)

 

Vascular invasion

  

0.398

Negative

35 (74.5)

33 (64.7)

 

Positive

12 (25.5)

18 (35.3)

 

Ki67

  

0.481

<14 %

30 (63.8)

29 (56.9)

 

≥14 %

17 (36.2)

22 (43.1)

 

Recurrence

  

0.021

No

40 (85.1)

33 (64.7)

 

Yes

7 (14.9)

18 (35.3)

 
  1. *P values calculated by log-rank testing; bold if statistically significant, P < 0.05.